Insider Buying: Neuronetics, Inc. (NASDAQ:STIM) Director Purchases 50,000 Shares of Stock

Neuronetics, Inc. (NASDAQ:STIM – Get Free Report) Director Robert Cascella bought 50,000 shares of Neuronetics stock in a transaction on Thursday, June 6th. The stock was acquired at an average price of $2.05 per share, with a total value of $102,500.00. Following the completion of the purchase, the director now directly owns 244,098 shares of […]

Related Keywords

United States ,William Blair ,Piper Sandler ,Robert Cascella ,Nasdaq ,Worth Venture Partners ,Dorsey Whitney Trust ,Securities Exchange Commission ,Sg Americas Securities ,Fielder Capital Group ,Neuronetics Inc ,Investment Advisers ,Get Free Report ,Director Robert Cascella ,Exchange Commission ,Venture Partners ,Whitney Trust ,Capital Group ,Neurostar Advanced Therapy System ,Neuronetics Daily ,